Kocher Gregor, Himmelmann Andreas
Medical Clinic B, Department of Internal Medicine, University Hospital Zurich, Switzerland.
Swiss Med Wkly. 2005 Jun 25;135(25-26):372-6. doi: 10.4414/smw.2005.11035.
Portal and mesenteric venous thrombosis (PVT) is an uncommon disease with serious consequences if not discovered early in order to prevent complications such as variceal bleeding and intestinal ischaemia. The objective of this study was to describe the clinical presentation and outcome of patients with PVT with a view to early diagnosis and treatment of this disease. The study was restricted to patients with PVT not caused by underlying liver cirrhosis.
To analyse important clinical characteristics of this entity we performed a retrospective study of 20 non-cirrhotic patients seen in our hospital from February 1998 to March 2003.
The main clinical symptom was abdominal pain (13 patients, 86%), sometimes in combination with diarrhoea and vomiting (5 patients, 33%), nausea and anorexia (3 patients). Laboratory signs were non-specific and diagnosis was usually by computed tomography (19 patients, 95%). Causative factors included prothrombotic states (9 patients, 45%) and/or local factors (5 patients, 25%). Complications must be expected from portal hypertension (15 patients, 75%), which was associated with variceal bleeding in 6 patients (30%). Bowel ischaemia (5 patients, 25%) and bowel infarction (2 patients) were less frequent. Treatment consisted of immediate anticoagulation in almost all cases (18 patients, 90%), while invasive approaches were followed in selected patients. The prognosis of PVT was good in patients without a severe underlying disease (median followup 21 months).
In agreement with other studies our results suggest that early diagnosis and treatment by immediate anticoagulation are important in preventing the serious consequences of portal and mesenteric vein occlusion. The role of more invasive approaches is less well defined. Since in 18 patients (90%) of the non-cirrhotic cases in the present series causative factors were found which may have therapeutic implications, aetiological screening seems worthwhile in every case with PVT.
门静脉和肠系膜静脉血栓形成(PVT)是一种罕见疾病,若不及早发现,会导致严重后果,如静脉曲张出血和肠缺血等并发症。本研究的目的是描述PVT患者的临床表现及预后情况,以期对该疾病进行早期诊断和治疗。本研究仅限于非潜在肝硬化所致的PVT患者。
为分析该疾病的重要临床特征,我们对1998年2月至2003年3月在我院就诊的20例非肝硬化患者进行了回顾性研究。
主要临床症状为腹痛(13例,86%),有时伴有腹泻和呕吐(5例,33%)、恶心和厌食(3例)。实验室检查结果无特异性,通常通过计算机断层扫描进行诊断(19例,95%)。病因包括血栓前状态(9例,45%)和/或局部因素(5例,25%)。必须预料到门静脉高压会引发并发症(15例,75%),其中6例(30%)伴有静脉曲张出血。肠缺血(5例,25%)和肠梗死(2例)相对较少见。几乎所有病例(18例,90%)的治疗均包括立即抗凝,而部分患者采用了侵入性治疗方法。无严重基础疾病患者的PVT预后良好(中位随访21个月)。
与其他研究一致,我们的结果表明,通过立即抗凝进行早期诊断和治疗对于预防门静脉和肠系膜静脉阻塞的严重后果很重要。侵入性更强的治疗方法的作用尚不太明确。由于本系列中非肝硬化病例中有18例(90%)发现了可能具有治疗意义的病因,因此对于每例PVT患者进行病因筛查似乎是值得的。